flecainide has been researched along with Dizzyness in 7 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Flecainide is an oral class IC antiarrhythmic drug whose most common extracardiac adverse reactions are "dizziness" and "visual disturbances." | 9.22 | A Possible Mechanism for Flecainide Induced Dizziness. ( Garaycochea, O; Manrique-Huarte, R; Pérez-Fernández, N; Riesgo, Á, 2022) |
| "During a one-week short-term in-hospital period, 60 patients with chronic ventricular arrhythmias were treated with 200 mg flecainide twice a day." | 7.67 | Flecainide: one-year efficacy in patients with chronic ventricular arrhythmias. ( Balakumaran, K; Hagemeijer, F; Hugenholtz, PG; Jovanovic, A; Lubsen, J; Polak, BC; Roelandt, J; ten Cate, FJ; Vanhaleweyk, G; Withagen, A, 1984) |
| "Flecainide is an oral class IC antiarrhythmic drug whose most common extracardiac adverse reactions are "dizziness" and "visual disturbances." | 5.22 | A Possible Mechanism for Flecainide Induced Dizziness. ( Garaycochea, O; Manrique-Huarte, R; Pérez-Fernández, N; Riesgo, Á, 2022) |
| "During a one-week short-term in-hospital period, 60 patients with chronic ventricular arrhythmias were treated with 200 mg flecainide twice a day." | 3.67 | Flecainide: one-year efficacy in patients with chronic ventricular arrhythmias. ( Balakumaran, K; Hagemeijer, F; Hugenholtz, PG; Jovanovic, A; Lubsen, J; Polak, BC; Roelandt, J; ten Cate, FJ; Vanhaleweyk, G; Withagen, A, 1984) |
| " The most frequently reported extracardiac adverse experiences were dizziness (30%) and visual disturbances (28%), often occurring in tandem." | 1.27 | Extracardiac adverse effects of flecainide. ( Gentzkow, GD; Sullivan, JY, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Garaycochea, O | 1 |
| Riesgo, Á | 1 |
| Manrique-Huarte, R | 1 |
| Pérez-Fernández, N | 1 |
| Lip, GY | 1 |
| Fauchier, L | 1 |
| Freedman, SB | 1 |
| Van Gelder, I | 1 |
| Natale, A | 1 |
| Gianni, C | 1 |
| Nattel, S | 1 |
| Potpara, T | 1 |
| Rienstra, M | 1 |
| Tse, HF | 1 |
| Lane, DA | 1 |
| Bonilla-Palomas, JL | 1 |
| López-López, JM | 1 |
| Moreno-Conde, M | 1 |
| Gallego de la Sacristana, A | 1 |
| Gámez-López, AL | 1 |
| Villar-Ráez, A | 1 |
| Conard, GJ | 1 |
| Carlson, GL | 1 |
| Frost, JW | 1 |
| Ober, RE | 1 |
| Leon, AS | 1 |
| Hunninghake, DB | 1 |
| Vanhaleweyk, G | 1 |
| Balakumaran, K | 1 |
| Lubsen, J | 1 |
| ten Cate, FJ | 1 |
| Jovanovic, A | 1 |
| Hagemeijer, F | 1 |
| Withagen, A | 1 |
| Polak, BC | 1 |
| Roelandt, J | 1 |
| Hugenholtz, PG | 1 |
| Gentzkow, GD | 1 |
| Sullivan, JY | 1 |
| Nestico, PF | 1 |
| Morganroth, J | 1 |
2 reviews available for flecainide and Dizzyness
| Article | Year |
|---|---|
A Possible Mechanism for Flecainide Induced Dizziness.
Topics: Aged; Bilateral Vestibulopathy; Dizziness; Flecainide; Head Impulse Test; Humans; Male; Vertigo; Ves | 2022 |
Atrial fibrillation.
Topics: Ablation Techniques; Anticoagulants; Aspirin; Atrial Fibrillation; Dizziness; Dyspnea; Electric Coun | 2016 |
5 other studies available for flecainide and Dizzyness
| Article | Year |
|---|---|
Type I Brugada electrocardiogram pattern induced by metoclopramide.
Topics: Brugada Syndrome; Dizziness; Dopamine Antagonists; Flecainide; Humans; Male; Metoclopramide; Middle | 2011 |
Plasma concentrations of flecainide acetate, a new antiarrhythmic agent, in humans.
Topics: Adult; Anti-Arrhythmia Agents; Chromatography, Gas; Dizziness; Drug Tolerance; Electrocardiography; | 1984 |
Flecainide: one-year efficacy in patients with chronic ventricular arrhythmias.
Topics: Adult; Aged; Arrhythmias, Cardiac; Chronic Disease; Dizziness; Drug Evaluation; Electrocardiography; | 1984 |
Extracardiac adverse effects of flecainide.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dizziness; Dyspnea; Flecainide; Headache; Humans; Naus | 1984 |
Flecainide: a new antiarrhythmic agent.
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Dizziness; Electrophysiology; Flecainide; Hemody | 1986 |